Andrea Raballo Selected Research

2-bromolysergic acid diethylamide (BOL)

1/2021	Anhedonia in the Psychosis Risk Syndrome: State and Trait Characteristics.
8/2020	Anhedonia in young people with first episode psychosis: a longitudinal study.
4/2020	Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Raballo Research Topics

Disease

32	Psychotic Disorders (Schizoaffective Disorder) 06/2022 - 01/2011
9	Schizophrenia (Dementia Praecox) 06/2022 - 01/2015
4	Mental Disorders (Mental Disorder) 01/2021 - 01/2018
3	Anhedonia 01/2021 - 04/2020
1	Aphasia (Dysphasia) 12/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Substance-Related Disorders (Drug Abuse) 11/2019
1	Hallucinations (Hallucination) 04/2012

Drug/Important Bio-Agent (IBA)

20	Polytetrafluoroethylene (Teflon)FDA Link 02/2022 - 01/2011
11	Antipsychotic Agents (Antipsychotics)IBA 06/2022 - 08/2016
3	2-bromolysergic acid diethylamide (BOL)IBA 01/2021 - 04/2020
2	Antidepressive Agents (Antidepressants)IBA 06/2022 - 01/2020
2	SolutionsIBA 12/2021 - 04/2012
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 12/2021 - 01/2021
1	Appetite Depressants (Anorectics)IBA 06/2022
1	mesoglycanIBA 01/2022
1	PlasticsIBA 11/2020
1	ceramide heptassaccharide (CHSC)IBA 11/2018
1	Genetic Markers (Genetic Marker)IBA 01/2018

Therapy/Procedure

1	CARE protocol 12/2021
1	Disarticulation 01/2016
1	Self-Testing 01/2015